# Eli Lilly announces $3B expansion of Pleasant Prairie manufacturing facility

Eli Lilly acquired a manufacturing facility in Pleasant Prairie, Wisconsin from Nexus Pharmaceuticals in 2024 and announced a $3 billion expansion to extend its global parenteral product manufacturing network. The expansion will add 750 jobs and bring total investment to $4 billion.

- Type: Expansion
- Announced: 2016-12-19
- Where: Pleasant Prairie, Wisconsin, United States
- Value: $3.00B
- Jobs: 750
- Status: announced
- Products: parenteral (injectable) medicines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eli Lilly and Company](https://endata.com/companies/16522.md)
- [Nexus Pharmaceuticals](https://endata.com/companies/16523.md) (target)

## Sources

- [kaba.org](https://www.kaba.org/advantages/proven-success/), 2016-12-19: "Today’s announcement represents our single largest U.S. manufacturing investment outside our home state of Indiana and will add to our ability to expand capacity to make both our existing and future pipeline of medicines right here in the Midwest."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.